announced today that it has received approval from the Food and Drug Administration (FDA) to begin U.S. marketing of its new Subcutaneous Needle Sets which the company is promoting as the HIgh Flo™ ...
CHESTER, N.Y.--(BUSINESS WIRE)--Innovative Health Sciences, LLC (“IHS” or the “Company”) management announced today that IHS has received FDA clearance for its Insignis™ Subcutaneous Needle Sets. This ...
DUBLIN--(BUSINESS WIRE)--The "Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030" report has been added to ResearchAndMarkets.com's offering. Biologics represent ...
The advent of large-protein biologics enabled the creation of breakthrough treatments for many chronic conditions, and this represents a multi-billion-dollar market. However, challenges exist with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback